Back to KYMR
GOLDMAN SACHS GROUP INC → KYMR
GOLDMAN SACHS GROUP INC KYMR Position History
Kymera Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$368K
Q2 2026
Peak value
$101.6M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $8.7M |
| Q2 2025 | $3.5M |
| Q3 2025 | $29.9M |
| Q3 2025 | $10.3M |
| Q4 2025 | $13.4M |
| Q4 2025 | $44.2M |
| Q4 2025 | $44.2M |
| Q4 2025 | $13.4M |
| Q1 2026 | $64.8M |
| Q1 2026 | $9.2M |
| Q2 2026 | $101.6M |
| Q2 2026 | $33.9M |
| Q2 2026 | $320K |
| Q2 2026 | $368K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $368K | 3.2K | — | — |
| Q2 2026 | $320K | 2.8K | — | — |
| Q2 2026 | $33.9M | 295.3K | — | — |
| Q2 2026 | $101.6M | 886.0K | — | — |
| Q1 2026 | $9.2M | 110.0K | — | — |
| Q1 2026 | $64.8M | 778.4K | — | — |
| Q4 2025 | $13.4M | 171.8K | — | — |
| Q4 2025 | $44.2M | 568.5K | — | — |
| Q4 2025 | $44.2M | 568.5K | — | — |
| Q4 2025 | $13.4M | 171.8K | — | — |
| Q3 2025 | $10.3M | 182.4K | — | — |
| Q3 2025 | $29.9M | 529.1K | — | — |
| Q2 2025 | $3.5M | 79.3K | — | — |
| Q2 2025 | $8.7M | 199.4K | — | — |